GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Clinical trial NCT03584516 · TERMINATED
Trial details
- NCT number
- NCT03584516
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-17
- Primary completion
- 2023-11-03
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.